The Global X Aging Population ETF (LNGR) is designed to track the performance, both in price appreciation and income generation, of the Indxx Global Longevity Thematic Index, prior to any management fees or operational expenses. To achieve this, it allocates over 80% of its total assets directly into the constituent securities of that benchmark. This underlying index targets publicly traded companies located in developed economies. These companies are strategically positioned to benefit from the growing demographic trend of increased human longevity and the global aging population. This encompasses various sectors such as biotechnology, innovative medical devices, pharmaceutical research and development, senior care facilities, and specialized healthcare providers.

Eli Lilly and Company

Amgen Inc.

Bristol-Myers Squibb Company

Regeneron Pharmaceuticals, Inc.

Boston Scientific Corporation

Johnson & Johnson

Biogen Inc.

AstraZeneca PLC

AbbVie Inc.

DexCom, Inc.

Healthcare

Real Estate

Global X Aging Population ETF

LNGR Holdings & Sector Breakdown